Powerus Receives Pakistan Ministry of Defence Order and Signs Strategic Memorandum of Understanding

Powerus received a limited procurement order from Pakistan’s Ministry of Defence for unmanned aerial systems and support, expanding its international defense business; financial terms were not disclosed. The company also signed a non-binding MOU for potential broader autonomous-defense cooperation, with any future programs subject to definitive contracts, U.S. export-control compliance and government approvals. Separately, Powerus’s merger with Nasdaq-listed Aureus Greenway Holdings (PUSA) remains targeted for Q4 2026 but is subject to customary closing and regulatory conditions.

Analysis

PUSA is likely to trade as a low-float, event-driven merger security rather than on discounted defense fundamentals until the transaction closes. With neither order value, delivery schedule, unit economics, nor funding terms disclosed, the market cannot translate the announcement into revenue or EBITDA; any sharp near-term rally would therefore be driven by narrative and scarcity rather than an underwriting change. The relevant verification catalyst over the next 1-3 months is SEC disclosure showing pro forma capitalization, Powerus backlog, customer concentration, cash runway, and the ownership/dilution mechanics at closing.

The more material constraint is export authorization, not demand. Pakistan exposure introduces a meaningful probability of licensing conditions, delivery delays, or program scope reductions, while an MOU has no contractual value and should receive no valuation credit. A denial, qualification, or prolonged review could also impair the broader international-sales multiple by demonstrating that Powerus's addressable market is politically constrained; conversely, a disclosed funded follow-on contract with approved export licenses would validate an overseas channel and improve working-capital visibility.

Contrarian view: investors may extrapolate a geopolitical engagement into a durable defense backlog before the combined company has public-company operating history. Small defense-platform firms can face negative cash conversion even when orders arrive, because inventory, testing, support, and compliance costs precede acceptance revenue. NDAQ has no direct earnings sensitivity; its relevance is limited to listing/compliance risk, which matters only insofar as it affects PUSA's ability to consummate and maintain the listing.

Key Decisions for Investors

• No fundamental long in PUSA solely on this release. Reassess after the next S-4 supplement or closing filing discloses order value, payment milestones, gross margin, export-license status, and post-merger fully diluted share count; absent those data, risk/reward is not quantifiable.
• For event-driven exposure, maintain only a small long PUSA position through the expected Q4 closing if the stock trades at a material discount to the implied merger value and liquidity is adequate. Exit on a merger-condition failure, Nasdaq deficiency notice, or disclosure of incremental financing that expands the fully diluted share count beyond the filed pro forma assumptions.
• Treat a funded, definitive Pakistan follow-on award plus demonstrated U.S. export approval as the 1-3 month upside trigger; that would justify revisiting a long because it converts a strategic claim into backlog. Treat an MOU lapse, license delay beyond management's delivery timeline, or cancellation/refund language as a hard thesis falsifier.
• Do not use NDAQ as a sympathy hedge or proxy trade. Any impact on Nasdaq is immaterial; PUSA-specific execution, regulatory, and financing risk dominates.